Healthcare
This function is exclusive for Premium subscribers
-
DATABASE (359)
-
ARTICLES (108)
B Capital Group is best known as the venture capital firm co-founded by Eduardo Saverin, co-founder of Facebook. Its investment thesis focuses on connecting highly innovative and agile startups with major corporates that are in need of innovation and have the resources to innovate. As such, B Capital has a special interest in B2B companies that have great potential to disrupt critical industries. This includes startups that are disrupting healthcare and biotechnology, as well as finance and insurance. B Capital has also supported some notable B2C companies, including coffee chain Kopi Kenangan and used car marketplace Carro.
B Capital Group is best known as the venture capital firm co-founded by Eduardo Saverin, co-founder of Facebook. Its investment thesis focuses on connecting highly innovative and agile startups with major corporates that are in need of innovation and have the resources to innovate. As such, B Capital has a special interest in B2B companies that have great potential to disrupt critical industries. This includes startups that are disrupting healthcare and biotechnology, as well as finance and insurance. B Capital has also supported some notable B2C companies, including coffee chain Kopi Kenangan and used car marketplace Carro.
Verlinvest is the investment diversification vehicle of the de Spoelberch family, the Belgian noble house, which founded the AB InBev beverage conglomerate. Founded in 1995, it currently manages over €1.6bn in assets across multiple geographies, including Europe, India, Southeast Asia and Latin America. Aside from investing in various F&B brands like Vita Coco (coconut water), F&B Asia (which operates various restaurant franchise brands in Southeast Asia) and Glaceau Vitamin Water, it has also backed e-commerce businesses like Global Fashion Group and Lazada, as well as Indian edtech platform Byju’s.
Verlinvest is the investment diversification vehicle of the de Spoelberch family, the Belgian noble house, which founded the AB InBev beverage conglomerate. Founded in 1995, it currently manages over €1.6bn in assets across multiple geographies, including Europe, India, Southeast Asia and Latin America. Aside from investing in various F&B brands like Vita Coco (coconut water), F&B Asia (which operates various restaurant franchise brands in Southeast Asia) and Glaceau Vitamin Water, it has also backed e-commerce businesses like Global Fashion Group and Lazada, as well as Indian edtech platform Byju’s.
Serena Ventures is a venture capital investment firm founded by professional tennis player and businesswoman Serena Williams. The company focuses on early-stage companies founded by young, diverse teams. Since it was founded in 2014, it has invested in more than 30 companies with a cumulative market cap of $12b. Coffee brand Kopi Kenangan is its first investment in the Indonesian market. Serena Ventures has invested in notable companies like plant-based meat maker Impossible Foods, cryptocurrency exchange Coinbase, as well as Serena Williams’ own fashion label, S by Serena.
Serena Ventures is a venture capital investment firm founded by professional tennis player and businesswoman Serena Williams. The company focuses on early-stage companies founded by young, diverse teams. Since it was founded in 2014, it has invested in more than 30 companies with a cumulative market cap of $12b. Coffee brand Kopi Kenangan is its first investment in the Indonesian market. Serena Ventures has invested in notable companies like plant-based meat maker Impossible Foods, cryptocurrency exchange Coinbase, as well as Serena Williams’ own fashion label, S by Serena.
Shanghai Guohe Capital was set up in 2009 by Shanghai International Group, a state-owned financial institution. It is China’s first private fund management company to obtain the qualification of private equity fund manager. The firm currently runs multiple funds with assets worth over RMB 10bn.
Shanghai Guohe Capital was set up in 2009 by Shanghai International Group, a state-owned financial institution. It is China’s first private fund management company to obtain the qualification of private equity fund manager. The firm currently runs multiple funds with assets worth over RMB 10bn.
A private equity arm of China state-backed conglomerate CITIC Group Corp., CITIC Private Equity Funds Management (also known as CITIC PE or CPE) is one of the largest PE investors in China. It was founded in June 2008, managing over RMB 100bn worth of assets including private equity, mezzanine and public market funds. With over 200 investors from home and abroad, CPE focuses on investment opportunities in diverse sectors like healthcare, consumer goods, Internet, technology, software, enterprise tech and real estate. The firm has made investments in more than 100 enterprises.
A private equity arm of China state-backed conglomerate CITIC Group Corp., CITIC Private Equity Funds Management (also known as CITIC PE or CPE) is one of the largest PE investors in China. It was founded in June 2008, managing over RMB 100bn worth of assets including private equity, mezzanine and public market funds. With over 200 investors from home and abroad, CPE focuses on investment opportunities in diverse sectors like healthcare, consumer goods, Internet, technology, software, enterprise tech and real estate. The firm has made investments in more than 100 enterprises.
DCP Capital is an international private equity firm that mainly invests in Asia. The DCP team previously led KKR and Morgan Stanley’s private equity businesses in Asia. Over the past 27 years, it has invested in a number of leading enterprises including Ping An Insurance, Mengniu Dairy, CICC and Haier Electronics. Its existing investors include leading sovereign wealth funds, pension funds, endowments, family offices and funds of funds (FOF) across the world.In April 2019, DCP successfully raised over $2bn for its first Greater China-focused USD fund known as DCP Capital Partners I. The fund mainly invests in diverse sectors including consumer goods, industrial technology, healthcare, agrifood, enterprise tech, financial services and technology, media & telecom (TMT).
DCP Capital is an international private equity firm that mainly invests in Asia. The DCP team previously led KKR and Morgan Stanley’s private equity businesses in Asia. Over the past 27 years, it has invested in a number of leading enterprises including Ping An Insurance, Mengniu Dairy, CICC and Haier Electronics. Its existing investors include leading sovereign wealth funds, pension funds, endowments, family offices and funds of funds (FOF) across the world.In April 2019, DCP successfully raised over $2bn for its first Greater China-focused USD fund known as DCP Capital Partners I. The fund mainly invests in diverse sectors including consumer goods, industrial technology, healthcare, agrifood, enterprise tech, financial services and technology, media & telecom (TMT).
Haier Medical, a health-focused IoT-concept brand, is grouped under Yinkang Life, an arm of the Haier Group Corporation. It is an integrated health platform comprising physical hospitals and online medical services. As to its rehabilitation for intensive illnesses, for example, Haier Medical has rehabilitation hospitals that offer both physical treatment and Internet-based consultation so that patients spend less time there than in a normal medical facility. Besides rehabilitation, Haier Medical also focuses on cancer treatment, aged care services, and family health management services. Overall, it has a network of 16 hospitals with 8,000 beds, serving over 1m people every year.
Haier Medical, a health-focused IoT-concept brand, is grouped under Yinkang Life, an arm of the Haier Group Corporation. It is an integrated health platform comprising physical hospitals and online medical services. As to its rehabilitation for intensive illnesses, for example, Haier Medical has rehabilitation hospitals that offer both physical treatment and Internet-based consultation so that patients spend less time there than in a normal medical facility. Besides rehabilitation, Haier Medical also focuses on cancer treatment, aged care services, and family health management services. Overall, it has a network of 16 hospitals with 8,000 beds, serving over 1m people every year.
Zhongguancun Longmen Investment
Investing in hi-tech IT, advanced manufacturing and biotechnology sectors – key pillars of China’s innovation-focused economy since 2017 – the Beijing government-backed Beijing Zhongguancun Longmen Investment manages about RMB 10bn via its first fund of the same name. The firm is founded and led by Xu Jinghong, former Chairman of Tsinghua Holdings, the investment and tech/R&D transfer arm of China’s most prestigious science and research university, whose R&D capacity was ranked in the third place of China’s top 500 enterprises in 2018. The LPs of the fund include social security funds, Beijing’s municipal government and the Haidian District government. Its portfolio enterprises are generally ranked in the top three of their respective industries. Among them, Qi An Xin Technology, which is listed in Shanghai and one of China’s biggest cybersecurity companies; Joy Wing Mao, one of China’s major fruits supply chain companies. In October of 2020, it invested RMB 100m into Beijing Immunochina Pharmaceutical, which develops innovative gene and cell therapies for curing malignant tumors. Longmen also provides mentoring and other expertise and support to its investee startups, especially those that plan to seek public listing.
Investing in hi-tech IT, advanced manufacturing and biotechnology sectors – key pillars of China’s innovation-focused economy since 2017 – the Beijing government-backed Beijing Zhongguancun Longmen Investment manages about RMB 10bn via its first fund of the same name. The firm is founded and led by Xu Jinghong, former Chairman of Tsinghua Holdings, the investment and tech/R&D transfer arm of China’s most prestigious science and research university, whose R&D capacity was ranked in the third place of China’s top 500 enterprises in 2018. The LPs of the fund include social security funds, Beijing’s municipal government and the Haidian District government. Its portfolio enterprises are generally ranked in the top three of their respective industries. Among them, Qi An Xin Technology, which is listed in Shanghai and one of China’s biggest cybersecurity companies; Joy Wing Mao, one of China’s major fruits supply chain companies. In October of 2020, it invested RMB 100m into Beijing Immunochina Pharmaceutical, which develops innovative gene and cell therapies for curing malignant tumors. Longmen also provides mentoring and other expertise and support to its investee startups, especially those that plan to seek public listing.
Fidelity China Special Situations PLC
Founded in 2010, Fidelity China Special Situations PLC (FCSS) is managed by Dale Nicholls who has worked at Fidelity International since 1996. Listed on the FTSE 250 Index, FCSS is said to be the UK’s largest China-focused investment trust with access to Fidelity's investment research resources and investment licenses in China.Focusing on companies that are most likely to benefit from China’s growth and changing economy, FCSS has invested in over 100 businesses in the country. Besides technology, it is also seeking opportunities in the consumer space and healthcare.
Founded in 2010, Fidelity China Special Situations PLC (FCSS) is managed by Dale Nicholls who has worked at Fidelity International since 1996. Listed on the FTSE 250 Index, FCSS is said to be the UK’s largest China-focused investment trust with access to Fidelity's investment research resources and investment licenses in China.Focusing on companies that are most likely to benefit from China’s growth and changing economy, FCSS has invested in over 100 businesses in the country. Besides technology, it is also seeking opportunities in the consumer space and healthcare.
Early-stage-focused VC firm with a €24m first fund mainly investing in B2B and B2C digital startups headquartered in Spain. Initial investment amounts range between €70,000 and €300,000, and followup investment amounts go up to €1m per company. Describing themselves as “momentum investors” seeking quick time-to-market projects, Encomenda Smart Capital was founded in 2017 and managed by renowned Spanish angel investors Carlos Blanco, Oriol Juncosa and Miguel Sanz Sanchez, along with a network of angel investors Encomenda supports the growth of startups' portfolios and helps startups to scale at national and international levels. Encomenda invests 30% in SaaS and in projects with a recurring income model; 20% are fintech, and they also bet on the human resources, edtech and healthcare. Just two out of 25 investments have folded up between 2017 and 2020, with half the fund monies committed. Encomenda is seeking to launch a second fund in 2022 focusing on Spanish and Portuguese startups, of €40m–€50m, and multi-stage, by starting in the early-stage investments, with follow-through investments in subsequent stages.
Early-stage-focused VC firm with a €24m first fund mainly investing in B2B and B2C digital startups headquartered in Spain. Initial investment amounts range between €70,000 and €300,000, and followup investment amounts go up to €1m per company. Describing themselves as “momentum investors” seeking quick time-to-market projects, Encomenda Smart Capital was founded in 2017 and managed by renowned Spanish angel investors Carlos Blanco, Oriol Juncosa and Miguel Sanz Sanchez, along with a network of angel investors Encomenda supports the growth of startups' portfolios and helps startups to scale at national and international levels. Encomenda invests 30% in SaaS and in projects with a recurring income model; 20% are fintech, and they also bet on the human resources, edtech and healthcare. Just two out of 25 investments have folded up between 2017 and 2020, with half the fund monies committed. Encomenda is seeking to launch a second fund in 2022 focusing on Spanish and Portuguese startups, of €40m–€50m, and multi-stage, by starting in the early-stage investments, with follow-through investments in subsequent stages.
Founded in 2019, Wens Capital is an independent business unit responsible for investment and M&A under Guangdong Wens Food Group which went public on Shenzhen Stock Exchange in 2015. Through two subsidiaries Wens Investment and Wens Equity Investment, it currently manages about RMB 10bn worth of assets and has invested in more than 50 companies. It mainly invests in military projects and companies from sectors of environmental protection, healthcare and TMT.
Founded in 2019, Wens Capital is an independent business unit responsible for investment and M&A under Guangdong Wens Food Group which went public on Shenzhen Stock Exchange in 2015. Through two subsidiaries Wens Investment and Wens Equity Investment, it currently manages about RMB 10bn worth of assets and has invested in more than 50 companies. It mainly invests in military projects and companies from sectors of environmental protection, healthcare and TMT.
Founded in 2013, Sino-Ocean Capital is the investment arm of the Chinese real estate developer Sino-Ocean Group. It mainly invests in the sectors of big data, healthcare, logistics, environmental protection, real estate and finance. It currently manages RMB 50bn worth assets and $700m US dollar funds. The limited partners include insurance companies, large-sized enterprises and sovereign wealth funds.In 2019, Sino-Ocean Capital launched a RMB 3-5bn fund to acquire logistics properties and planned to invest RMB 48bn in logistics over the next five years. It also on the track to raise $1.5bn for its latest real estate fund to invest in offices in Beijing.
Founded in 2013, Sino-Ocean Capital is the investment arm of the Chinese real estate developer Sino-Ocean Group. It mainly invests in the sectors of big data, healthcare, logistics, environmental protection, real estate and finance. It currently manages RMB 50bn worth assets and $700m US dollar funds. The limited partners include insurance companies, large-sized enterprises and sovereign wealth funds.In 2019, Sino-Ocean Capital launched a RMB 3-5bn fund to acquire logistics properties and planned to invest RMB 48bn in logistics over the next five years. It also on the track to raise $1.5bn for its latest real estate fund to invest in offices in Beijing.
Greater Bay Area Homeland Development Fund
With the aim of supporting Hong Kong to develop into a world-class tech innovation center and cooperating with Guangdong and Macau enterprises to support the development of the Guangdong-Hong Kong-Macao Greater Bay Area, large-sized mainland enterprises operating in Hong Kong, Hong Kong companies, mainland private firms and new economy enterprises initiated Greater Bay Area Homeland Development Fund in 2018. With a total capital volume of over HK$100bn, it is managed by Greater Bay Area Homeland Investments. The fund will also provide help to enterprises in the Greater Bay Area to export products to overseas markets.
With the aim of supporting Hong Kong to develop into a world-class tech innovation center and cooperating with Guangdong and Macau enterprises to support the development of the Guangdong-Hong Kong-Macao Greater Bay Area, large-sized mainland enterprises operating in Hong Kong, Hong Kong companies, mainland private firms and new economy enterprises initiated Greater Bay Area Homeland Development Fund in 2018. With a total capital volume of over HK$100bn, it is managed by Greater Bay Area Homeland Investments. The fund will also provide help to enterprises in the Greater Bay Area to export products to overseas markets.
With currently over $21bn of AUM, Baring Private Equity Asia (BPEA) was started in Hong Kong in 1997 by Jean Eric Salata, as the regional Asian PE investment arm of UK-based Baring Private Equity Partners. With $300m in its first fund, it focused on riding China’s economic rise spurred by the country’s market liberalization. In 2000, Salata led a management buyout of BPEA and continues to head the firm today as CEO and Founding Partner. BPEA has invested in more than 100 companies, across healthcare, logistics, IT services, media, education, financial services and retail. It is one of the largest independent PE firms in Asia and has eight offices across the continent.With offices in China, India, Japan, Australia, and Singapore, it currently has around 43 portfolio companies, almost all Asia-based, across multiple business segments in tech and non-tech startups, especially in bricks-and-mortar education establishments. It also makes acquisitions, including most recently of US outsourcing services company Virtusa in February 2021.Other recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and in the November 2020 $198m Series D round of Chinese computer coding for kids edtech Codemao.
With currently over $21bn of AUM, Baring Private Equity Asia (BPEA) was started in Hong Kong in 1997 by Jean Eric Salata, as the regional Asian PE investment arm of UK-based Baring Private Equity Partners. With $300m in its first fund, it focused on riding China’s economic rise spurred by the country’s market liberalization. In 2000, Salata led a management buyout of BPEA and continues to head the firm today as CEO and Founding Partner. BPEA has invested in more than 100 companies, across healthcare, logistics, IT services, media, education, financial services and retail. It is one of the largest independent PE firms in Asia and has eight offices across the continent.With offices in China, India, Japan, Australia, and Singapore, it currently has around 43 portfolio companies, almost all Asia-based, across multiple business segments in tech and non-tech startups, especially in bricks-and-mortar education establishments. It also makes acquisitions, including most recently of US outsourcing services company Virtusa in February 2021.Other recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and in the November 2020 $198m Series D round of Chinese computer coding for kids edtech Codemao.
Concept Investimentos is a Brazilian mid-market private equity investor based in São Paulo. Focusing mainly on medtech, the firm was established in 2016 with its first investment in Maquira, a leading manufacturer of dental products in Brazil. It has invested in three companies so far, including participation in the R$1.7m seed investment round of Brazilian edtech Blox.Founding partner Rafael Pilotto Gonçalez previously worked at Pacific Investimentos’ private equity division and Pacific’s partnership with One Equity Partners, JPM’s former global private equity arm in Brazil. He has also worked for the private equity arm of Banco Votorantim and London-based private equity firm Actis.
Concept Investimentos is a Brazilian mid-market private equity investor based in São Paulo. Focusing mainly on medtech, the firm was established in 2016 with its first investment in Maquira, a leading manufacturer of dental products in Brazil. It has invested in three companies so far, including participation in the R$1.7m seed investment round of Brazilian edtech Blox.Founding partner Rafael Pilotto Gonçalez previously worked at Pacific Investimentos’ private equity division and Pacific’s partnership with One Equity Partners, JPM’s former global private equity arm in Brazil. He has also worked for the private equity arm of Banco Votorantim and London-based private equity firm Actis.
SWITCH Singapore 2021: How to harness the power of the deep tech ecosystem
Investor Jason Illian of Koch Disruptive Technologies talks talent, scaling for deep tech startups, and why longer gestation periods and mid-course pivots don’t have to be deal breakers
SWITCH Singapore 2021: Benefits and challenges of AI applications in healthcare
Medical experts and healthcare startups agree AI can contribute more to healthcare beyond improving diagnosis and personalized treatment, but hurdles still remain
South Summit 2021: Martin Varavsky, Leandro Sigman on post-Covid healthcare trends
Serial entrepreneur Martin Varavsky and Insud Pharma Chairman Leandro Sigman share their thoughts and projections on the future of health tech
Intudo Ventures: Grooming returning overseas talent for an Indonesia-only bet
Combining the experience and networks of foreign-educated Indonesians with local distribution channels, Intudo’s hyperlocal strategy has attracted $200m in managed assets
ARTICARES: Personalized, more affordable arm rehab therapy at home
Using adaptive AI, its H-Man robot works like an occupational therapist, assessing patient’s performance and adjusting the complexity of training tasks in real time
TherapyChat: Using AI to scale and improve accuracy in mental health treatment
Business for the Spanish startup has surged ninefold since Covid-19, with the company expanding to the UK and Italy
Accelerating Asia bets on unicorn wave from MSME digitalization, logistics
The investor-accelerator’s sixth batch will start accepting applications in December, with greater ESG focus and a pledge to donate 1% of profit on investments to charity
Mindtera: Building mental resilience through bite-sized lessons
Mindtera wants to nip mental health issues in the bud by equipping working adults with skills to navigate work challenges and personal relationships, using their phones
Sequoia Capital China holds steady with investments in healthcare, biotech and green economy
China’s most active investor increases bets on sectors beyond the consumer internet and edtech recently hurt by regulatory clampdown
Senior Deli: Creating easy-to-swallow, appealing food for dysphagia sufferers
Already supplying to over 200 senior homes and hospitals, the Future Food Asia 2021 co-winner uses proprietary tech to make nutritious, affordable texture-modified foods for people with swallowing difficulties
New sectors, strategies come into play as investors respond to China's Big Tech curbs
Amid the crackdown on China’s tech giants, some investors are sussing out less risky sectors, while heavyweights like BlackRock and Fidelity stay in for the long haul
Aimentia: Pioneering mental health AI SaaS seeks to improve diagnosis as demand surges
Barcelona-based Aimentia supports the oft-overlooked mental health segment through digitalization and analytics, going beyond therapy platforms
Zoundream: Deciphering and mining the data in baby cries
The world’s first algorithm to translate baby cries into actionable insights for parents and hospitals seeks to boost early detection of pathologies and developmental disorders
Nuuk, the cooler box poised to disrupt cold chain logistics
Barcelona-based startup Groenlandia Tech has developed a smart cooler box to track and monitor biological samples, providing an extra layer of security and control during transport
4YFN: Investment booms across Europe during pandemic
Speaking at the recent 4YFN conference, prolific European startup investor Mattias Ljungman provided a highly optimistic assessment of the continent's current ecosystem strength and climate for seed funding
POPULAR DATABASE
